I believe that PARD could possibly be a 50% gainer by end of 1H2010. As you said, potentially price moving forward-looking events coming up as well: http://finance.yahoo.com/news/Poniard-Pharmaceuticals-prnews-1983655420.html?x=0&.v=1 If the talks w/ the FDA go well, this could definitely go back into the $3s/$4s, imo. GL.